Table 2.

Cell subset frequency and TREC content of the patient and control populations

Control
(n = 28)
Early RA
(n = 26)
Resistant RA
(n = 32)
Naive CD4+ T cells* 11 (3.85-25.6) 1.50 (0.15-12.8) 3.7 (0.28-10.3) 
Memory CD4+ T cells* 44 (15-61) 36 (15-53) 35 (12-68)  
Atypical RBbright CD4+
T cells* 
2.5 (0.1-7.5) 10.2 (1.0-33) 14 (5-40)  
Total TREC (% cells) 4.77 (1.5-10.85) 0.82 (0.01-6.40) 1.85 (0.33-4.7) 
Naive TREC (% cells) 8.0 (2.68-17.4) 4.70 (0.47-8.96) 1.77 (0.09-7.24) 
Control
(n = 28)
Early RA
(n = 26)
Resistant RA
(n = 32)
Naive CD4+ T cells* 11 (3.85-25.6) 1.50 (0.15-12.8) 3.7 (0.28-10.3) 
Memory CD4+ T cells* 44 (15-61) 36 (15-53) 35 (12-68)  
Atypical RBbright CD4+
T cells* 
2.5 (0.1-7.5) 10.2 (1.0-33) 14 (5-40)  
Total TREC (% cells) 4.77 (1.5-10.85) 0.82 (0.01-6.40) 1.85 (0.33-4.7) 
Naive TREC (% cells) 8.0 (2.68-17.4) 4.70 (0.47-8.96) 1.77 (0.09-7.24) 
*

Median (range) values represent percentages of the total CD4+ T-cell population.

Median (range) values represent the TREC content of CD4+T-cell populations.

Close Modal

or Create an Account

Close Modal
Close Modal